Insights

US heart transplant waitlists need policy updates. Experts favor a tiered system for patients with mechanical circulatory support (MCS) complications, prioritizing those with high mortality risk and addressing geographic disparities.

Area of Science:

  • Cardiology
  • Transplant Surgery
  • Health Policy

Background:

  • US heart allocation policy (2006) requires revision due to significant changes in transplant waitlists.
  • Advances in mechanical circulatory support (MCS) improve survival but Status 1A mortality remains high.
  • Current listing criteria may disadvantage specific patient subgroups, and geographic disparities persist.

Purpose of the Study:

  • To discuss critical issues in US heart allocation policy.
  • To gather expert opinions on potential policy revisions.
  • To identify concepts for future policy development.

Main Methods:

  • A forum was convened to discuss US heart allocation policy.
  • A 25-question survey on heart allocation policy was administered.
  • Participants included 84 heart transplant experts from 51 US centers and representatives from OPTN/UNOS and SRTR.

Main Results:

  • Strong consensus for a more tiered heart allocation system.
  • Interest in prioritizing patients with MCS complications, high sensitization, severe arrhythmias, or restrictive physiology.
  • Support for geographically modified distribution based on population, though differences exist between center sizes.

Conclusions:

  • The current US heart allocation policy needs significant revision.
  • A more refined, tiered system is favored to address patient subgroups and geographic disparities.
  • While a comprehensive heart allocation score is not yet feasible, specific patient factors warrant improved prioritization.

Related Concept Videos

Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
592
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
1.2K
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
614
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.4K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.5K
Ischemic Heart Disease: Overview01:17

Ischemic Heart Disease: Overview

Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
4.1K